These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17120478)

  • 61. Methylmalonic acidaemia in a 7-month-old following maternal highly active antiretroviral therapy during pregnancy.
    Silf K; McMaster P; Hendriksz C
    AIDS; 2007 Aug; 21(13):1835-6. PubMed ID: 17690593
    [No Abstract]   [Full Text] [Related]  

  • 62. "High" antiretroviral deintensification, a strategy to avoid drug interactions and unfavourable long-term effects of HAART.
    Lanzafame M; Piacentini D; Lattuada E; Rizzardo S; Chiesi S; Vento S
    Infect Dis (Lond); 2018 Oct; 50(10):788-790. PubMed ID: 29916752
    [No Abstract]   [Full Text] [Related]  

  • 63. Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV.
    Eke AC; Mirochnick M; Lockman S
    N Engl J Med; 2023 Jan; 388(4):344-356. PubMed ID: 36720135
    [No Abstract]   [Full Text] [Related]  

  • 64. Antiretroviral reduction: is it time to rethink the unthinkable?
    Colasanti J; Marconi VC; Taiwo B
    AIDS; 2014 Apr; 28(7):943-7. PubMed ID: 24401641
    [No Abstract]   [Full Text] [Related]  

  • 65. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.
    Ekouevi DK
    N Engl J Med; 2010 Nov; 363(20):1969; author reply 1970. PubMed ID: 21067395
    [No Abstract]   [Full Text] [Related]  

  • 66. [HIV and pregnancy].
    Petry KU
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():63-5. PubMed ID: 16385880
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Pregnancy and human immunodeficiency virus].
    Ceccaldi PF; Gavard L; Mandelbrot L
    J Gynecol Obstet Biol Reprod (Paris); 2008 Mar; 37 Suppl 1():34-40. PubMed ID: 18501294
    [No Abstract]   [Full Text] [Related]  

  • 68. Laboratory abnormalities among HIV-1-infected pregnant women receiving antiretrovirals in Latin America and the Caribbean.
    Ceriotto M; Harris DR; Duarte G; Gonin R; Aguiar RP; Warley EM; Madi JM; Zala CA; Read JS;
    AIDS Patient Care STDS; 2008 Mar; 22(3):167-71. PubMed ID: 18338942
    [No Abstract]   [Full Text] [Related]  

  • 69. Human immunodeficiency virus and pregnancy.
    Reshi P; Lone IM
    Arch Gynecol Obstet; 2010 May; 281(5):781-92. PubMed ID: 20035338
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Implementing anti-retroviral triple therapy to prevent HIV mother-to-child transmission: a public health approach in resource-limited settings.
    Marazzi CM; Germano P; Liotta G; Guidotti G; Loureiro S; Gomes Ada C; Blazquez MC; Narciso P; Perno CF; Mancinelli S; Altan AD; Nielsen-Saines K; Palombi L
    Eur J Pediatr; 2007 Dec; 166(12):1305-7. PubMed ID: 17235520
    [No Abstract]   [Full Text] [Related]  

  • 71. Infant of 22 months of age with no anomalies born from a HCV- and HIV-infected mother under treatment with pegylated interferon, ribavirin and antiretroviral therapy during the first 16 weeks of pregnancy.
    Labarga P; Pinilla J; Cachorro I; Ruiz Y
    Reprod Toxicol; 2007; 24(3-4):414-6. PubMed ID: 17698320
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.
    Ryom L; Boesecke C; Bracchi M; Ambrosioni J; Pozniak A; Arribas J; Behrens G; Mallon P; Puoti M; Rauch A; Miro JM; Kirk O; Marzolini C; Lundgren JD; Battegay M;
    HIV Med; 2018 May; 19(5):309-315. PubMed ID: 29493093
    [TBL] [Abstract][Full Text] [Related]  

  • 73. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Management of antiretroviral therapy in neonates, children, and adolescents.
    Neely M; Kovacs A
    Curr HIV/AIDS Rep; 2004 Jun; 1(2):97-104. PubMed ID: 16091229
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antiretroviral Therapy in Relation to Birth Outcomes among HIV-infected Women: A Cohort Study.
    Li N; Sando MM; Spiegelman D; Hertzmark E; Liu E; Sando D; Machumi L; Chalamilla G; Fawzi W
    J Infect Dis; 2016 Apr; 213(7):1057-64. PubMed ID: 26265780
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Infants. Risk of birth defects low in those exposed to ART in womb.
    AIDS Policy Law; 2014 Jun; 29(7):3. PubMed ID: 25087244
    [No Abstract]   [Full Text] [Related]  

  • 78. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
    Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.
    Ciaranello AL; Seage GR; Freedberg KA; Weinstein MC; Lockman S; Walensky RP
    AIDS; 2008 Nov; 22(17):2359-69. PubMed ID: 18981776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.